PLI scheme envisages manufacturing of 41 Bulk Drugs with a total outlay of Rs. 6,940 cr. during the tenure of the scheme from 2020-21 to 2029-30
Contributing to lower risk of potentially carcinogenic nitrosamine impurities in pharmaceuticals
MoU to serve as the establishment of an Academic Collaboration in Ayurveda and Thai Traditional Medicine
Academic and Policy Research to get further boost, RIS will bring forth Ayush Service Sector report soon
Both the Ministries signed MoU for anaemia control among adolescent girls using Ayurveda interventions
Experts discussed the latest innovations, challenges, & collaborative solutions in the fight against TB at NHWIC-2024 held at AIIMS, Delhi
Net product sales in the fourth quarter of 2023 include the recognition of $0.6 billion from deferred revenue, related to Gavi, the Vaccine Alliance
We are achieving the target of developed India by making our young children healthy today
Subscribe To Our Newsletter & Stay Updated